| 0 |
PERFORMANCE ENHANCING PRODUCT USE |
27 |
0.2727 |
| 1 |
VIRILISM |
25 |
0.2273 |
| 2 |
COOMBS POSITIVE HAEMOLYTIC ANAEMIA |
87 |
0.1895 |
| 3 |
POLYCYTHAEMIA |
302 |
0.1462 |
| 4 |
CERVIX CARCINOMA STAGE IV |
20 |
0.1379 |
| 5 |
SECONDARY HYPOGONADISM |
43 |
0.1303 |
| 6 |
TOXIC CARDIOMYOPATHY |
29 |
0.1295 |
| 7 |
ACNE FULMINANS |
24 |
0.1224 |
| 8 |
BLOOD TESTOSTERONE INCREASED |
241 |
0.1120 |
| 9 |
ENLARGED CLITORIS |
18 |
0.1091 |
| 10 |
EXPULSION OF MEDICATION |
57 |
0.1078 |
| 11 |
PRODUCT DEPOSIT |
147 |
0.0943 |
| 12 |
PRECOCIOUS PUBERTY |
52 |
0.0911 |
| 13 |
HEPATIC ADENOMA |
43 |
0.0832 |
| 14 |
RENAL ARTERY THROMBOSIS |
24 |
0.0777 |
| 15 |
CLEAR CELL RENAL CELL CARCINOMA |
50 |
0.0718 |
| 16 |
BREAST HYPERPLASIA |
25 |
0.0710 |
| 17 |
CENTRAL SEROUS CHORIORETINOPATHY |
47 |
0.0688 |
| 18 |
BLOOD TESTOSTERONE DECREASED |
458 |
0.0669 |
| 19 |
OESTRADIOL INCREASED |
20 |
0.0664 |
| 20 |
CRANIOPHARYNGIOMA |
21 |
0.0633 |
| 21 |
IDIOPATHIC INTRACRANIAL HYPERTENSION |
121 |
0.0538 |
| 22 |
BLOOD GROWTH HORMONE INCREASED |
28 |
0.0502 |
| 23 |
TESTICULAR ATROPHY |
43 |
0.0493 |
| 24 |
METAPLASIA |
23 |
0.0487 |
| 25 |
MUSCLE MASS |
22 |
0.0487 |
| 26 |
BLOOD TESTOSTERONE ABNORMAL |
53 |
0.0479 |
| 27 |
MESENTERIC VEIN THROMBOSIS |
47 |
0.0471 |
| 28 |
ENDOMETRIAL ADENOCARCINOMA |
28 |
0.0440 |
| 29 |
BLOOD OESTROGEN INCREASED |
25 |
0.0424 |
| 30 |
BLOOD OESTROGEN DECREASED |
28 |
0.0398 |
| 31 |
INFERTILITY MALE |
18 |
0.0398 |
| 32 |
HYPOGONADISM |
40 |
0.0396 |
| 33 |
RENAL INFARCT |
56 |
0.0387 |
| 34 |
LYMPHADENITIS |
90 |
0.0371 |
| 35 |
POLYCYTHAEMIA VERA |
29 |
0.0354 |
| 36 |
FOCAL SEGMENTAL GLOMERULOSCLEROSIS |
52 |
0.0324 |
| 37 |
CARDIAC VENTRICULAR THROMBOSIS |
38 |
0.0294 |
| 38 |
INSULIN-LIKE GROWTH FACTOR INCREASED |
42 |
0.0294 |
| 39 |
CORONARY ARTERY DISSECTION |
25 |
0.0291 |
| 40 |
PRODUCT DELIVERY MECHANISM ISSUE |
155 |
0.0288 |
| 41 |
HAEMATOCRIT INCREASED |
65 |
0.0285 |
| 42 |
ISCHAEMIA |
130 |
0.0283 |
| 43 |
OBSTRUCTIVE SLEEP APNOEA SYNDROME |
40 |
0.0274 |
| 44 |
MYOCARDIAL FIBROSIS |
23 |
0.0274 |
| 45 |
BRUGADA SYNDROME |
25 |
0.0242 |
| 46 |
HEREDITARY ANGIOEDEMA |
241 |
0.0224 |
| 47 |
CARDIAC DEATH |
27 |
0.0224 |
| 48 |
UNMASKING OF PREVIOUSLY UNIDENTIFIED DISEASE |
24 |
0.0218 |
| 49 |
CEREBRAL VENOUS SINUS THROMBOSIS |
18 |
0.0213 |
| 50 |
RECALLED PRODUCT |
35 |
0.0202 |
| 51 |
INFARCTION |
137 |
0.0200 |
| 52 |
PITUITARY TUMOUR BENIGN |
32 |
0.0196 |
| 53 |
PRODUCT INEFFECTIVE FOR UNAPPROVED USE |
52 |
0.0195 |
| 54 |
IMPLANT SITE SWELLING |
19 |
0.0186 |
| 55 |
PRODUCT PHYSICAL CONSISTENCY ISSUE |
103 |
0.0186 |
| 56 |
ECONOMIC PROBLEM |
282 |
0.0186 |
| 57 |
IMPLANT SITE INFECTION |
43 |
0.0185 |
| 58 |
BONE DEMINERALISATION |
18 |
0.0170 |
| 59 |
LEFT VENTRICULAR HYPERTROPHY |
72 |
0.0168 |
| 60 |
LYMPHOPROLIFERATIVE DISORDER |
48 |
0.0163 |
| 61 |
RED BLOOD CELL COUNT INCREASED |
44 |
0.0159 |
| 62 |
PORTAL VEIN THROMBOSIS |
50 |
0.0155 |
| 63 |
ACUTE MYOCARDIAL INFARCTION |
448 |
0.0152 |
| 64 |
HAEMOGLOBIN INCREASED |
69 |
0.0151 |
| 65 |
QUALITY OF LIFE DECREASED |
202 |
0.0150 |
| 66 |
IMPLANT SITE PAIN |
66 |
0.0148 |
| 67 |
INVASIVE DUCTAL BREAST CARCINOMA |
40 |
0.0147 |
| 68 |
CEREBRAL VENOUS THROMBOSIS |
26 |
0.0143 |
| 69 |
HAEMOLYSIS |
110 |
0.0142 |
| 70 |
DEEP VEIN THROMBOSIS |
902 |
0.0139 |
| 71 |
ISCHAEMIC CARDIOMYOPATHY |
42 |
0.0137 |
| 72 |
MYELOFIBROSIS |
41 |
0.0135 |
| 73 |
LIBIDO INCREASED |
27 |
0.0133 |
| 74 |
PRODUCT ODOUR ABNORMAL |
139 |
0.0133 |
| 75 |
ENDOMETRIAL CANCER |
29 |
0.0132 |
| 76 |
HYPERCOAGULATION |
24 |
0.0126 |
| 77 |
SELF-MEDICATION |
51 |
0.0124 |
| 78 |
PHYSICAL DISABILITY |
53 |
0.0120 |
| 79 |
PAPILLOEDEMA |
54 |
0.0119 |
| 80 |
CORONARY ARTERY THROMBOSIS |
23 |
0.0114 |
| 81 |
LIQUID PRODUCT PHYSICAL ISSUE |
83 |
0.0114 |
| 82 |
CEREBROSPINAL FLUID LEAKAGE |
21 |
0.0114 |
| 83 |
THROMBOPHLEBITIS SUPERFICIAL |
34 |
0.0112 |
| 84 |
THROMBOCYTOSIS |
41 |
0.0112 |
| 85 |
CORONARY ARTERY DISEASE |
331 |
0.0109 |
| 86 |
VENTRICULAR HYPERTROPHY |
26 |
0.0104 |
| 87 |
MIGRAINE WITH AURA |
28 |
0.0103 |
| 88 |
ADRENOCORTICAL INSUFFICIENCY ACUTE |
20 |
0.0102 |
| 89 |
PULMONARY INFARCTION |
24 |
0.0101 |
| 90 |
PRESCRIBED OVERDOSE |
195 |
0.0101 |
| 91 |
CARDIOVASCULAR DISORDER |
255 |
0.0100 |
| 92 |
CARDIOMYOPATHY |
147 |
0.0099 |
| 93 |
ANHEDONIA |
258 |
0.0098 |
| 94 |
PRE-EXISTING CONDITION IMPROVED |
61 |
0.0098 |
| 95 |
INTRACRANIAL PRESSURE INCREASED |
54 |
0.0097 |
| 96 |
CUSHINGOID |
31 |
0.0096 |
| 97 |
HAIR GROWTH ABNORMAL |
66 |
0.0095 |
| 98 |
SLEEP APNOEA SYNDROME |
176 |
0.0092 |
| 99 |
SWOLLEN TONGUE |
288 |
0.0092 |
| 100 |
PULMONARY EMBOLISM |
876 |
0.0092 |
| 101 |
LACUNAR INFARCTION |
22 |
0.0092 |
| 102 |
INTRACARDIAC THROMBUS |
28 |
0.0091 |
| 103 |
PRODUCT CONTAMINATION PHYSICAL |
23 |
0.0090 |
| 104 |
ACCIDENTAL EXPOSURE |
37 |
0.0089 |
| 105 |
HEART INJURY |
22 |
0.0088 |
| 106 |
CHOLESTATIC LIVER INJURY |
19 |
0.0085 |
| 107 |
PROSTATOMEGALY |
33 |
0.0084 |
| 108 |
LOSS OF EMPLOYMENT |
25 |
0.0083 |
| 109 |
EMBOLISM VENOUS |
25 |
0.0082 |
| 110 |
HORMONE LEVEL ABNORMAL |
40 |
0.0082 |
| 111 |
BENIGN PROSTATIC HYPERPLASIA |
42 |
0.0081 |
| 112 |
PRIAPISM |
28 |
0.0081 |
| 113 |
CONGESTIVE CARDIOMYOPATHY |
33 |
0.0079 |
| 114 |
TESTICULAR PAIN |
25 |
0.0079 |
| 115 |
MULTIPLE USE OF SINGLE-USE PRODUCT |
44 |
0.0078 |
| 116 |
OPTIC ISCHAEMIC NEUROPATHY |
30 |
0.0077 |
| 117 |
POOR QUALITY PRODUCT ADMINISTERED |
80 |
0.0076 |
| 118 |
ERECTILE DYSFUNCTION |
193 |
0.0075 |
| 119 |
SOCIAL PROBLEM |
31 |
0.0075 |
| 120 |
SUDDEN CARDIAC DEATH |
25 |
0.0073 |
| 121 |
LOSS OF LIBIDO |
65 |
0.0072 |
| 122 |
HIGH DENSITY LIPOPROTEIN DECREASED |
24 |
0.0072 |
| 123 |
FAMILY STRESS |
22 |
0.0071 |
| 124 |
ARTERIOSCLEROSIS CORONARY ARTERY |
47 |
0.0071 |
| 125 |
ANGIOEDEMA |
311 |
0.0070 |
| 126 |
OSTEOPENIA |
105 |
0.0069 |
| 127 |
SNORING |
26 |
0.0069 |
| 128 |
HEPATOCELLULAR CARCINOMA |
52 |
0.0068 |
| 129 |
NEOPLASM RECURRENCE |
23 |
0.0068 |
| 130 |
RENAL CELL CARCINOMA |
33 |
0.0067 |
| 131 |
ANORGASMIA |
18 |
0.0066 |
| 132 |
PLANTAR FASCIITIS |
22 |
0.0066 |
| 133 |
BUNDLE BRANCH BLOCK RIGHT |
30 |
0.0065 |
| 134 |
IMPAIRED WORK ABILITY |
139 |
0.0065 |
| 135 |
VENOUS THROMBOSIS |
25 |
0.0064 |
| 136 |
PERIPHERAL ISCHAEMIA |
26 |
0.0064 |
| 137 |
AORTIC STENOSIS |
22 |
0.0063 |
| 138 |
PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION |
39 |
0.0063 |
| 139 |
DEVICE DELIVERY SYSTEM ISSUE |
168 |
0.0061 |
| 140 |
PRODUCT CONTAINER ISSUE |
52 |
0.0061 |
| 141 |
MYOCARDIAL INFARCTION |
1055 |
0.0060 |
| 142 |
ACUTE CORONARY SYNDROME |
50 |
0.0060 |
| 143 |
CAROTID ARTERY STENOSIS |
21 |
0.0060 |
| 144 |
LEFT VENTRICULAR DYSFUNCTION |
40 |
0.0060 |
| 145 |
BLOOD THYROID STIMULATING HORMONE DECREASED |
27 |
0.0059 |
| 146 |
PERIPHERAL VASCULAR DISORDER |
30 |
0.0058 |
| 147 |
AUTOIMMUNE THYROIDITIS |
22 |
0.0058 |
| 148 |
AORTIC ANEURYSM |
44 |
0.0058 |
| 149 |
DYSPHONIA |
337 |
0.0058 |
| 150 |
ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD |
39 |
0.0057 |
| 151 |
SPLENOMEGALY |
67 |
0.0057 |
| 152 |
ATRIAL FLUTTER |
45 |
0.0056 |
| 153 |
PRODUCT ADMINISTRATION INTERRUPTED |
44 |
0.0056 |
| 154 |
WOUND COMPLICATION |
19 |
0.0055 |
| 155 |
LACERATION |
52 |
0.0055 |
| 156 |
LEFT VENTRICULAR FAILURE |
19 |
0.0055 |
| 157 |
THROMBOSIS |
440 |
0.0055 |
| 158 |
PLATELET COUNT ABNORMAL |
33 |
0.0055 |
| 159 |
ANEURYSM |
27 |
0.0054 |
| 160 |
MUSCLE RUPTURE |
21 |
0.0054 |
| 161 |
NEPHROPATHY |
50 |
0.0053 |
| 162 |
SERUM FERRITIN INCREASED |
28 |
0.0053 |
| 163 |
OSTEONECROSIS |
174 |
0.0053 |
| 164 |
DRUG ADMINISTERED AT INAPPROPRIATE SITE |
55 |
0.0052 |
| 165 |
ARTERIOSCLEROSIS |
49 |
0.0052 |
| 166 |
AORTIC VALVE INCOMPETENCE |
22 |
0.0052 |
| 167 |
DYSLIPIDAEMIA |
26 |
0.0051 |
| 168 |
CEREBROVASCULAR ACCIDENT |
865 |
0.0051 |
| 169 |
DRUG ABUSE |
425 |
0.0051 |
| 170 |
APPLICATION SITE RASH |
69 |
0.0050 |
| 171 |
PRODUCT RESIDUE PRESENT |
27 |
0.0050 |
| 172 |
FEAR |
134 |
0.0050 |
| 173 |
EMBOLISM |
41 |
0.0049 |
| 174 |
SWELLING FACE |
321 |
0.0049 |
| 175 |
PROSTATIC SPECIFIC ANTIGEN INCREASED |
67 |
0.0049 |
| 176 |
HYPERLIPIDAEMIA |
58 |
0.0048 |
| 177 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
264 |
0.0048 |
| 178 |
IMMUNE THROMBOCYTOPENIA |
22 |
0.0048 |
| 179 |
NEPHROGENIC ANAEMIA |
22 |
0.0047 |
| 180 |
SKIN PAPILLOMA |
19 |
0.0047 |
| 181 |
MUSCLE FATIGUE |
20 |
0.0047 |
| 182 |
PROSTATIC DISORDER |
26 |
0.0047 |
| 183 |
VISUAL FIELD DEFECT |
34 |
0.0047 |
| 184 |
ECCHYMOSIS |
32 |
0.0047 |
| 185 |
TRANSIENT ISCHAEMIC ATTACK |
157 |
0.0046 |
| 186 |
POOR QUALITY DRUG ADMINISTERED |
30 |
0.0046 |
| 187 |
SKIN LACERATION |
50 |
0.0046 |
| 188 |
CORONARY ARTERY OCCLUSION |
63 |
0.0046 |
| 189 |
PRODUCT PHYSICAL ISSUE |
92 |
0.0046 |
| 190 |
CARDIOMEGALY |
56 |
0.0045 |
| 191 |
PRODUCT ADMINISTERED AT INAPPROPRIATE SITE |
83 |
0.0045 |
| 192 |
RECALLED PRODUCT ADMINISTERED |
43 |
0.0045 |
| 193 |
FEELING OF DESPAIR |
21 |
0.0045 |
| 194 |
MULTIPLE INJURIES |
28 |
0.0044 |
| 195 |
SPINAL OSTEOARTHRITIS |
39 |
0.0044 |
| 196 |
CARDIAC FAILURE CONGESTIVE |
355 |
0.0044 |
| 197 |
NERVE INJURY |
49 |
0.0044 |
| 198 |
HORDEOLUM |
19 |
0.0044 |
| 199 |
NOCTURIA |
53 |
0.0044 |
| 200 |
PSYCHIATRIC SYMPTOM |
32 |
0.0043 |
| 201 |
EMOTIONAL DISORDER |
132 |
0.0043 |
| 202 |
APPLICATION SITE IRRITATION |
53 |
0.0043 |
| 203 |
MITRAL VALVE INCOMPETENCE |
48 |
0.0042 |
| 204 |
APLASTIC ANAEMIA |
22 |
0.0042 |
| 205 |
CARDIAC FAILURE ACUTE |
28 |
0.0042 |
| 206 |
FOOD CRAVING |
22 |
0.0042 |
| 207 |
HEPATOMEGALY |
41 |
0.0042 |
| 208 |
AFFECTIVE DISORDER |
32 |
0.0041 |
| 209 |
ENERGY INCREASED |
24 |
0.0041 |
| 210 |
PRODUCT ADMINISTRATION ERROR |
82 |
0.0041 |
| 211 |
ATELECTASIS |
39 |
0.0040 |
| 212 |
MYOCARDITIS |
45 |
0.0039 |
| 213 |
VENTRICULAR FIBRILLATION |
43 |
0.0039 |
| 214 |
FLANK PAIN |
36 |
0.0038 |
| 215 |
BRAIN INJURY |
38 |
0.0038 |
| 216 |
INTERVERTEBRAL DISC DEGENERATION |
35 |
0.0038 |
| 217 |
STREPTOCOCCAL INFECTION |
21 |
0.0038 |
| 218 |
APPLICATION SITE PAIN |
83 |
0.0038 |
| 219 |
PRODUCT SOLUBILITY ABNORMAL |
19 |
0.0038 |
| 220 |
BODY HEIGHT DECREASED |
40 |
0.0037 |
| 221 |
SCOLIOSIS |
23 |
0.0037 |
| 222 |
ANGINA UNSTABLE |
24 |
0.0037 |
| 223 |
PLATELET COUNT INCREASED |
48 |
0.0037 |
| 224 |
PERIORBITAL OEDEMA |
19 |
0.0037 |
| 225 |
DIVERTICULUM |
26 |
0.0037 |
| 226 |
SOMNAMBULISM |
24 |
0.0037 |
| 227 |
ARTHROPOD BITE |
27 |
0.0036 |
| 228 |
ISCHAEMIC STROKE |
65 |
0.0036 |
| 229 |
BRAIN FOG |
57 |
0.0036 |
| 230 |
BLOOD TRIGLYCERIDES INCREASED |
64 |
0.0036 |
| 231 |
LOW DENSITY LIPOPROTEIN INCREASED |
28 |
0.0036 |
| 232 |
THERAPEUTIC PRODUCT EFFECT DECREASED |
162 |
0.0036 |
| 233 |
CONCUSSION |
28 |
0.0036 |
| 234 |
DRUG INTOLERANCE |
347 |
0.0036 |
| 235 |
ANXIETY |
1020 |
0.0036 |
| 236 |
SEXUAL DYSFUNCTION |
42 |
0.0036 |
| 237 |
CORONARY ARTERY STENOSIS |
18 |
0.0036 |
| 238 |
RHABDOMYOLYSIS |
149 |
0.0036 |
| 239 |
RENAL TUBULAR NECROSIS |
35 |
0.0036 |
| 240 |
CONCOMITANT DISEASE AGGRAVATED |
22 |
0.0036 |
| 241 |
DECREASED ACTIVITY |
38 |
0.0035 |
| 242 |
ATRIAL FIBRILLATION |
342 |
0.0035 |
| 243 |
MALIGNANT MELANOMA |
47 |
0.0035 |
| 244 |
GLOMERULAR FILTRATION RATE DECREASED |
43 |
0.0035 |
| 245 |
TEMPERATURE INTOLERANCE |
36 |
0.0035 |
| 246 |
MYELODYSPLASTIC SYNDROME |
50 |
0.0035 |
| 247 |
INCORRECT DOSE ADMINISTERED BY DEVICE |
90 |
0.0034 |
| 248 |
HICCUPS |
28 |
0.0034 |
| 249 |
HYPERCALCAEMIA |
42 |
0.0034 |
| 250 |
SPINAL COMPRESSION FRACTURE |
28 |
0.0034 |
| 251 |
ROTATOR CUFF SYNDROME |
43 |
0.0033 |
| 252 |
CARDIOGENIC SHOCK |
48 |
0.0033 |
| 253 |
END STAGE RENAL DISEASE |
61 |
0.0033 |
| 254 |
ARTERIAL OCCLUSIVE DISEASE |
26 |
0.0033 |
| 255 |
SKIN INFECTION |
37 |
0.0033 |
| 256 |
EXOSTOSIS |
30 |
0.0033 |
| 257 |
POST-TRAUMATIC STRESS DISORDER |
22 |
0.0033 |
| 258 |
BRAIN NEOPLASM |
30 |
0.0033 |
| 259 |
PROCEDURAL COMPLICATION |
25 |
0.0033 |
| 260 |
MYOCARDIAL ISCHAEMIA |
37 |
0.0032 |
| 261 |
GOUT |
58 |
0.0032 |
| 262 |
DECREASED INTEREST |
19 |
0.0032 |
| 263 |
EYE MOVEMENT DISORDER |
22 |
0.0032 |
| 264 |
LIMB INJURY |
87 |
0.0032 |
| 265 |
ANGER |
108 |
0.0032 |
| 266 |
VITAMIN D DEFICIENCY |
31 |
0.0032 |
| 267 |
PETECHIAE |
33 |
0.0032 |
| 268 |
MUSCLE ATROPHY |
40 |
0.0032 |
| 269 |
UPPER-AIRWAY COUGH SYNDROME |
26 |
0.0032 |
| 270 |
NASAL DISCOMFORT |
25 |
0.0032 |
| 271 |
SQUAMOUS CELL CARCINOMA OF SKIN |
19 |
0.0031 |
| 272 |
CHRONIC KIDNEY DISEASE |
239 |
0.0031 |
| 273 |
POLLAKIURIA |
131 |
0.0031 |
| 274 |
GINGIVAL PAIN |
25 |
0.0031 |
| 275 |
OSTEOPOROSIS |
129 |
0.0031 |
| 276 |
MUSCLE STRAIN |
27 |
0.0031 |
| 277 |
AFFECT LABILITY |
30 |
0.0031 |
| 278 |
HAEMOGLOBIN ABNORMAL |
20 |
0.0031 |
| 279 |
SEASONAL ALLERGY |
44 |
0.0031 |
| 280 |
NIGHT SWEATS |
100 |
0.0031 |
| 281 |
FRUSTRATION TOLERANCE DECREASED |
25 |
0.0031 |
| 282 |
GINGIVAL BLEEDING |
42 |
0.0031 |
| 283 |
OBESITY |
49 |
0.0031 |
| 284 |
APPLICATION SITE PRURITUS |
69 |
0.0030 |
| 285 |
BREAST CANCER FEMALE |
81 |
0.0030 |
| 286 |
PRODUCT FORMULATION ISSUE |
20 |
0.0030 |
| 287 |
INFUSION SITE SWELLING |
19 |
0.0030 |
| 288 |
BASAL CELL CARCINOMA |
47 |
0.0030 |
| 289 |
CHROMATURIA |
68 |
0.0030 |
| 290 |
MAJOR DEPRESSION |
22 |
0.0030 |
| 291 |
BONE DENSITY DECREASED |
94 |
0.0030 |
| 292 |
OBSESSIVE-COMPULSIVE DISORDER |
24 |
0.0030 |
| 293 |
PRODUCT SUBSTITUTION ISSUE |
172 |
0.0030 |
| 294 |
BLINDNESS TRANSIENT |
22 |
0.0030 |
| 295 |
NO ADVERSE EVENT |
539 |
0.0030 |
| 296 |
INTERVERTEBRAL DISC PROTRUSION |
65 |
0.0030 |
| 297 |
JOINT INJURY |
63 |
0.0029 |
| 298 |
PRODUCT LABEL ISSUE |
20 |
0.0029 |
| 299 |
POLYURIA |
24 |
0.0029 |
| 300 |
APPLICATION SITE VESICLES |
19 |
0.0029 |
| 301 |
MENISCUS INJURY |
18 |
0.0029 |
| 302 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
50 |
0.0029 |
| 303 |
TENDON RUPTURE |
36 |
0.0029 |
| 304 |
EMOTIONAL DISTRESS |
351 |
0.0029 |
| 305 |
INJURY |
203 |
0.0029 |
| 306 |
LARGE INTESTINE POLYP |
20 |
0.0029 |
| 307 |
WALKING AID USER |
19 |
0.0029 |
| 308 |
POOR QUALITY SLEEP |
62 |
0.0029 |
| 309 |
LEUKOCYTOSIS |
52 |
0.0029 |
| 310 |
NEPHROLITHIASIS |
131 |
0.0029 |
| 311 |
BACK INJURY |
31 |
0.0028 |
| 312 |
BRAIN OEDEMA |
36 |
0.0028 |
| 313 |
HEPATIC ENZYME INCREASED |
194 |
0.0028 |
| 314 |
SKIN MASS |
19 |
0.0028 |
| 315 |
HEART RATE IRREGULAR |
64 |
0.0028 |
| 316 |
APPLICATION SITE ERYTHEMA |
74 |
0.0028 |
| 317 |
MULTIPLE ALLERGIES |
22 |
0.0028 |
| 318 |
ADRENAL INSUFFICIENCY |
34 |
0.0028 |
| 319 |
BONE DISORDER |
51 |
0.0028 |
| 320 |
MOOD SWINGS |
89 |
0.0028 |
| 321 |
BREAST TENDERNESS |
21 |
0.0028 |
| 322 |
MIDDLE INSOMNIA |
52 |
0.0028 |
| 323 |
OSTEOARTHRITIS |
118 |
0.0028 |
| 324 |
RENAL CYST |
22 |
0.0028 |
| 325 |
HEAD INJURY |
87 |
0.0027 |
| 326 |
PANIC ATTACK |
100 |
0.0027 |
| 327 |
INTENTIONAL PRODUCT MISUSE |
240 |
0.0027 |
| 328 |
CYST |
34 |
0.0027 |
| 329 |
NEURALGIA |
66 |
0.0027 |
| 330 |
IMPAIRED GASTRIC EMPTYING |
37 |
0.0027 |
| 331 |
CHOLECYSTECTOMY |
31 |
0.0027 |
| 332 |
APPLICATION SITE REACTION |
19 |
0.0027 |
| 333 |
DRUG EFFECT LESS THAN EXPECTED |
40 |
0.0027 |
| 334 |
CELLULITIS |
136 |
0.0027 |
| 335 |
VITAMIN D DECREASED |
23 |
0.0027 |
| 336 |
MYOPATHY |
23 |
0.0027 |
| 337 |
IRRITABILITY |
160 |
0.0027 |
| 338 |
CEREBRAL INFARCTION |
65 |
0.0027 |
| 339 |
PRODUCT ADHESION ISSUE |
95 |
0.0027 |
| 340 |
THERAPEUTIC RESPONSE UNEXPECTED |
119 |
0.0026 |
| 341 |
ACUTE RESPIRATORY FAILURE |
51 |
0.0026 |
| 342 |
TENDONITIS |
41 |
0.0026 |
| 343 |
CARPAL TUNNEL SYNDROME |
37 |
0.0026 |
| 344 |
BODY TEMPERATURE DECREASED |
26 |
0.0026 |
| 345 |
HEPATIC STEATOSIS |
49 |
0.0026 |
| 346 |
TOOTH FRACTURE |
29 |
0.0026 |
| 347 |
DERMATITIS CONTACT |
30 |
0.0026 |
| 348 |
SCAR |
45 |
0.0026 |
| 349 |
SINUS DISORDER |
52 |
0.0026 |
| 350 |
CHOLELITHIASIS |
86 |
0.0026 |
| 351 |
MUSCULOSKELETAL DISCOMFORT |
45 |
0.0026 |
| 352 |
PARANOIA |
45 |
0.0026 |
| 353 |
INCREASED TENDENCY TO BRUISE |
24 |
0.0026 |
| 354 |
MIGRAINE |
248 |
0.0026 |
| 355 |
MENTAL STATUS CHANGES |
72 |
0.0026 |
| 356 |
HYPERCHOLESTEROLAEMIA |
25 |
0.0026 |
| 357 |
MUSCULOSKELETAL CHEST PAIN |
40 |
0.0026 |
| 358 |
PERSONALITY CHANGE |
24 |
0.0026 |
| 359 |
AMNESIA |
168 |
0.0026 |
| 360 |
BIPOLAR DISORDER |
28 |
0.0026 |
| 361 |
DEPRESSION |
586 |
0.0026 |
| 362 |
PULMONARY THROMBOSIS |
28 |
0.0026 |
| 363 |
HAEMORRHAGIC STROKE |
20 |
0.0026 |
| 364 |
MANIA |
42 |
0.0026 |
| 365 |
SQUAMOUS CELL CARCINOMA |
24 |
0.0025 |
| 366 |
CARDIAC MURMUR |
22 |
0.0025 |
| 367 |
DISTURBANCE IN ATTENTION |
137 |
0.0025 |
| 368 |
SINUS TACHYCARDIA |
36 |
0.0025 |
| 369 |
PRODUCT PACKAGING ISSUE |
24 |
0.0025 |
| 370 |
PLATELET COUNT DECREASED |
269 |
0.0025 |
| 371 |
THINKING ABNORMAL |
47 |
0.0025 |
| 372 |
DRUG-INDUCED LIVER INJURY |
79 |
0.0025 |
| 373 |
TRICUSPID VALVE INCOMPETENCE |
20 |
0.0025 |
| 374 |
MENTAL IMPAIRMENT |
61 |
0.0025 |
| 375 |
SPINAL OPERATION |
31 |
0.0025 |
| 376 |
UNEVALUABLE EVENT |
190 |
0.0025 |
| 377 |
PNEUMONIA BACTERIAL |
23 |
0.0025 |
| 378 |
GROIN PAIN |
22 |
0.0025 |
| 379 |
PULMONARY MASS |
37 |
0.0025 |
| 380 |
ANGINA PECTORIS |
71 |
0.0025 |
| 381 |
PRODUCT USE COMPLAINT |
39 |
0.0025 |
| 382 |
RESTLESS LEGS SYNDROME |
45 |
0.0025 |
| 383 |
PROTEINURIA |
47 |
0.0025 |
| 384 |
HYPERSENSITIVITY |
457 |
0.0025 |
| 385 |
DRUG LEVEL DECREASED |
25 |
0.0025 |
| 386 |
MYOSITIS |
22 |
0.0024 |
| 387 |
RED BLOOD CELL COUNT DECREASED |
70 |
0.0024 |
| 388 |
CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR |
82 |
0.0024 |
| 389 |
TOOTH INFECTION |
32 |
0.0024 |
| 390 |
LIGAMENT SPRAIN |
24 |
0.0024 |
| 391 |
FEELING DRUNK |
18 |
0.0024 |
| 392 |
MOOD ALTERED |
66 |
0.0024 |
| 393 |
ROAD TRAFFIC ACCIDENT |
101 |
0.0024 |
| 394 |
HYPERSOMNIA |
69 |
0.0024 |
| 395 |
HAEMOGLOBIN DECREASED |
247 |
0.0024 |
| 396 |
DEPRESSED MOOD |
127 |
0.0024 |
| 397 |
GASTRITIS |
63 |
0.0024 |
| 398 |
PRODUCT PRESCRIBING ERROR |
57 |
0.0024 |
| 399 |
WEIGHT FLUCTUATION |
25 |
0.0024 |
| 400 |
HYPERHIDROSIS |
307 |
0.0024 |
| 401 |
RIB FRACTURE |
49 |
0.0024 |
| 402 |
BLOOD PRESSURE INCREASED |
363 |
0.0024 |
| 403 |
FOOT FRACTURE |
45 |
0.0024 |
| 404 |
PRODUCT DISTRIBUTION ISSUE |
22 |
0.0024 |
| 405 |
CONTUSION |
228 |
0.0024 |
| 406 |
GYNAECOMASTIA |
73 |
0.0024 |
| 407 |
INSURANCE ISSUE |
36 |
0.0024 |
| 408 |
TINNITUS |
108 |
0.0023 |
| 409 |
DENTAL CARIES |
26 |
0.0023 |
| 410 |
INSOMNIA |
626 |
0.0023 |
| 411 |
FOOT DEFORMITY |
26 |
0.0023 |
| 412 |
EAR DISCOMFORT |
24 |
0.0023 |
| 413 |
GASTROOESOPHAGEAL REFLUX DISEASE |
188 |
0.0023 |
| 414 |
BLOOD LACTATE DEHYDROGENASE INCREASED |
37 |
0.0023 |
| 415 |
HYPERTENSION |
494 |
0.0023 |
| 416 |
APATHY |
34 |
0.0023 |
| 417 |
PANCREATITIS |
123 |
0.0023 |
| 418 |
SUICIDAL IDEATION |
213 |
0.0023 |
| 419 |
PRODUCT QUALITY ISSUE |
316 |
0.0023 |
| 420 |
ANKLE FRACTURE |
36 |
0.0023 |
| 421 |
TOOTHACHE |
42 |
0.0023 |
| 422 |
CHEST PAIN |
429 |
0.0023 |
| 423 |
THERAPEUTIC RESPONSE DECREASED |
140 |
0.0023 |
| 424 |
FEELING JITTERY |
44 |
0.0023 |
| 425 |
EYE INFECTION |
26 |
0.0023 |
| 426 |
AGGRESSION |
115 |
0.0023 |
| 427 |
ELECTROCARDIOGRAM ABNORMAL |
18 |
0.0023 |
| 428 |
PAIN |
1407 |
0.0023 |
| 429 |
IMPAIRED DRIVING ABILITY |
26 |
0.0023 |
| 430 |
ASTHENIA |
860 |
0.0023 |
| 431 |
BLOOD GLUCOSE FLUCTUATION |
25 |
0.0023 |
| 432 |
PALLOR |
62 |
0.0023 |
| 433 |
MICTURITION URGENCY |
26 |
0.0023 |
| 434 |
HOT FLUSH |
171 |
0.0023 |
| 435 |
BLOOD CREATININE INCREASED |
148 |
0.0023 |
| 436 |
TOOTH ABSCESS |
23 |
0.0023 |
| 437 |
INFUSION SITE ERYTHEMA |
19 |
0.0023 |
| 438 |
CARDIAC ARREST |
185 |
0.0022 |
| 439 |
SLEEP DISORDER |
158 |
0.0022 |
| 440 |
JOINT RANGE OF MOTION DECREASED |
30 |
0.0022 |
| 441 |
NECK PAIN |
125 |
0.0022 |
| 442 |
UPPER RESPIRATORY TRACT INFECTION |
103 |
0.0022 |
| 443 |
NEPHROPATHY TOXIC |
25 |
0.0022 |
| 444 |
BACK DISORDER |
36 |
0.0022 |
| 445 |
EATING DISORDER |
47 |
0.0022 |
| 446 |
ACUTE HEPATIC FAILURE |
30 |
0.0022 |
| 447 |
ABSCESS |
35 |
0.0022 |
| 448 |
DEVICE DEFECTIVE |
38 |
0.0022 |
| 449 |
RENAL IMPAIRMENT |
184 |
0.0022 |
| 450 |
PERIPHERAL COLDNESS |
30 |
0.0022 |
| 451 |
CHOLECYSTITIS |
26 |
0.0022 |
| 452 |
BLOOD COUNT ABNORMAL |
33 |
0.0022 |
| 453 |
INFUSION RELATED REACTION |
144 |
0.0022 |
| 454 |
INTENTIONAL PRODUCT USE ISSUE |
190 |
0.0022 |
| 455 |
NERVE COMPRESSION |
20 |
0.0022 |
| 456 |
BLOOD PRESSURE SYSTOLIC INCREASED |
42 |
0.0022 |
| 457 |
LOCALISED INFECTION |
52 |
0.0021 |
| 458 |
ACUTE KIDNEY INJURY |
329 |
0.0021 |
| 459 |
OEDEMA PERIPHERAL |
262 |
0.0021 |
| 460 |
INITIAL INSOMNIA |
22 |
0.0021 |
| 461 |
BURSITIS |
26 |
0.0021 |
| 462 |
HYPERTHYROIDISM |
31 |
0.0021 |
| 463 |
BEDRIDDEN |
28 |
0.0021 |
| 464 |
HYPERBILIRUBINAEMIA |
22 |
0.0021 |
| 465 |
PULMONARY CONGESTION |
28 |
0.0021 |
| 466 |
RENAL FAILURE |
282 |
0.0021 |
| 467 |
GASTROINTESTINAL INFECTION |
19 |
0.0021 |
| 468 |
PAIN IN JAW |
60 |
0.0021 |
| 469 |
HAEMATOCRIT DECREASED |
42 |
0.0021 |
| 470 |
OFF LABEL USE |
1851 |
0.0021 |
| 471 |
SMALL INTESTINAL OBSTRUCTION |
26 |
0.0021 |
| 472 |
BLOOD IRON DECREASED |
25 |
0.0021 |
| 473 |
CARDIAC DISORDER |
196 |
0.0021 |
| 474 |
STAPHYLOCOCCAL INFECTION |
69 |
0.0021 |
| 475 |
BLOOD UREA INCREASED |
35 |
0.0021 |
| 476 |
LACRIMATION INCREASED |
63 |
0.0021 |
| 477 |
BACK PAIN |
484 |
0.0021 |
| 478 |
BALANCE DISORDER |
180 |
0.0021 |
| 479 |
THYROID DISORDER |
32 |
0.0021 |
| 480 |
MASS |
29 |
0.0021 |
| 481 |
NODULE |
27 |
0.0021 |
| 482 |
LETHARGY |
119 |
0.0021 |
| 483 |
FEELING ABNORMAL |
495 |
0.0021 |
| 484 |
POST PROCEDURAL HAEMORRHAGE |
24 |
0.0021 |
| 485 |
BLOOD CHOLESTEROL INCREASED |
96 |
0.0021 |
| 486 |
PHOTOSENSITIVITY REACTION |
34 |
0.0021 |
| 487 |
PRESYNCOPE |
50 |
0.0021 |
| 488 |
DRUG ADMINISTRATION ERROR |
63 |
0.0021 |
| 489 |
FLUSHING |
208 |
0.0020 |
| 490 |
HAEMATOMA |
53 |
0.0020 |
| 491 |
BLOOD CALCIUM DECREASED |
23 |
0.0020 |
| 492 |
SKIN LESION |
56 |
0.0020 |
| 493 |
SINUSITIS |
209 |
0.0020 |
| 494 |
MUSCLE TWITCHING |
47 |
0.0020 |
| 495 |
DECREASED IMMUNE RESPONSIVENESS |
20 |
0.0020 |
| 496 |
LUNG INFILTRATION |
18 |
0.0020 |
| 497 |
LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR |
18 |
0.0020 |
| 498 |
HEADACHE |
1274 |
0.0020 |
| 499 |
NEEDLE ISSUE |
59 |
0.0020 |
| 500 |
HIP ARTHROPLASTY |
31 |
0.0020 |
| 501 |
PRODUCT STORAGE ERROR |
177 |
0.0020 |
| 502 |
PRODUCT AVAILABILITY ISSUE |
46 |
0.0020 |
| 503 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
97 |
0.0020 |
| 504 |
INFUSION SITE PAIN |
26 |
0.0020 |
| 505 |
MYALGIA |
343 |
0.0020 |
| 506 |
PULMONARY HYPERTENSION |
42 |
0.0020 |
| 507 |
BONE PAIN |
118 |
0.0020 |
| 508 |
DEVICE RELATED INFECTION |
31 |
0.0020 |
| 509 |
PARAESTHESIA ORAL |
29 |
0.0020 |
| 510 |
IMPAIRED HEALING |
66 |
0.0020 |
| 511 |
COORDINATION ABNORMAL |
28 |
0.0020 |
| 512 |
WHITE BLOOD CELL COUNT INCREASED |
77 |
0.0020 |
| 513 |
HYPONATRAEMIA |
113 |
0.0020 |
| 514 |
IRRITABLE BOWEL SYNDROME |
43 |
0.0020 |
| 515 |
HYPOTHYROIDISM |
64 |
0.0020 |
| 516 |
HAEMORRHOIDS |
39 |
0.0020 |
| 517 |
LABORATORY TEST ABNORMAL |
59 |
0.0020 |
| 518 |
DRUG INTERACTION |
317 |
0.0020 |
| 519 |
SURGERY |
117 |
0.0020 |
| 520 |
WEIGHT DECREASED |
557 |
0.0020 |
| 521 |
CONSTIPATION |
433 |
0.0020 |
| 522 |
SUPRAVENTRICULAR TACHYCARDIA |
19 |
0.0020 |
| 523 |
FATIGUE |
1541 |
0.0020 |
| 524 |
ORAL CANDIDIASIS |
26 |
0.0020 |
| 525 |
PRODUCT DISPENSING ERROR |
43 |
0.0020 |
| 526 |
TUBULOINTERSTITIAL NEPHRITIS |
37 |
0.0020 |
| 527 |
TREATMENT NONCOMPLIANCE |
108 |
0.0020 |
| 528 |
WEIGHT INCREASED |
442 |
0.0020 |
| 529 |
IMMUNE SYSTEM DISORDER |
26 |
0.0020 |
| 530 |
DISORIENTATION |
78 |
0.0020 |
| 531 |
NO THERAPEUTIC RESPONSE |
24 |
0.0020 |
| 532 |
HEART RATE DECREASED |
69 |
0.0020 |
| 533 |
SLUGGISHNESS |
20 |
0.0020 |
| 534 |
SKIN HAEMORRHAGE |
29 |
0.0020 |
| 535 |
IRON DEFICIENCY ANAEMIA |
18 |
0.0019 |
| 536 |
DRUG EFFECT DECREASED |
105 |
0.0019 |
| 537 |
BLOOD URINE PRESENT |
37 |
0.0019 |
| 538 |
PRODUCT USE IN UNAPPROVED INDICATION |
481 |
0.0019 |
| 539 |
THERAPY CHANGE |
19 |
0.0019 |
| 540 |
MENTAL DISORDER |
84 |
0.0019 |
| 541 |
COLD SWEAT |
34 |
0.0019 |
| 542 |
POST PROCEDURAL COMPLICATION |
37 |
0.0019 |
| 543 |
VENTRICULAR EXTRASYSTOLES |
20 |
0.0019 |
| 544 |
NEUROPATHY PERIPHERAL |
183 |
0.0019 |
| 545 |
HEAD DISCOMFORT |
34 |
0.0019 |
| 546 |
INJECTION SITE MASS |
71 |
0.0019 |
| 547 |
ABNORMAL DREAMS |
53 |
0.0019 |
| 548 |
TENDERNESS |
20 |
0.0019 |
| 549 |
WRIST FRACTURE |
23 |
0.0019 |
| 550 |
TACHYPNOEA |
26 |
0.0019 |
| 551 |
BLOOD PRESSURE ABNORMAL |
38 |
0.0019 |
| 552 |
UPPER LIMB FRACTURE |
38 |
0.0019 |
| 553 |
INCORRECT PRODUCT STORAGE |
25 |
0.0019 |
| 554 |
TYPE 2 DIABETES MELLITUS |
64 |
0.0019 |
| 555 |
INTERNATIONAL NORMALISED RATIO INCREASED |
54 |
0.0019 |
| 556 |
FIBROMYALGIA |
46 |
0.0019 |
| 557 |
BRONCHITIS |
140 |
0.0019 |
| 558 |
ARTHROPATHY |
105 |
0.0019 |
| 559 |
CLOSTRIDIUM DIFFICILE COLITIS |
20 |
0.0019 |
| 560 |
COGNITIVE DISORDER |
88 |
0.0019 |
| 561 |
HYPERKALAEMIA |
66 |
0.0019 |
| 562 |
VENTRICULAR TACHYCARDIA |
31 |
0.0019 |
| 563 |
MALNUTRITION |
21 |
0.0019 |
| 564 |
DIABETES MELLITUS |
143 |
0.0019 |
| 565 |
DISABILITY |
37 |
0.0019 |
| 566 |
BREAST CANCER METASTATIC |
20 |
0.0019 |
| 567 |
HERNIA |
36 |
0.0019 |
| 568 |
LIVER FUNCTION TEST ABNORMAL |
54 |
0.0019 |
| 569 |
DIZZINESS POSTURAL |
18 |
0.0019 |
| 570 |
EUPHORIC MOOD |
19 |
0.0019 |
| 571 |
HIATUS HERNIA |
24 |
0.0019 |
| 572 |
DYSURIA |
68 |
0.0018 |
| 573 |
ABNORMAL BEHAVIOUR |
73 |
0.0018 |
| 574 |
BLOOD GLUCOSE ABNORMAL |
34 |
0.0018 |
| 575 |
NASAL CONGESTION |
108 |
0.0018 |
| 576 |
PSYCHOTIC DISORDER |
54 |
0.0018 |
| 577 |
DERMATITIS ALLERGIC |
23 |
0.0018 |
| 578 |
AGITATION |
134 |
0.0018 |
| 579 |
THROMBOCYTOPENIA |
204 |
0.0018 |
| 580 |
BONE MARROW FAILURE |
37 |
0.0018 |
| 581 |
BLADDER DISORDER |
18 |
0.0018 |
| 582 |
IMPAIRED QUALITY OF LIFE |
26 |
0.0018 |
| 583 |
AGEUSIA |
45 |
0.0018 |
| 584 |
COAGULOPATHY |
30 |
0.0018 |
| 585 |
HEART RATE INCREASED |
178 |
0.0018 |
| 586 |
MUSCLE SPASMS |
329 |
0.0018 |
| 587 |
EPISTAXIS |
134 |
0.0018 |
| 588 |
DRUG DOSE OMISSION BY DEVICE |
140 |
0.0018 |
| 589 |
WITHDRAWAL SYNDROME |
75 |
0.0018 |
| 590 |
JAUNDICE |
48 |
0.0018 |
| 591 |
BURNING SENSATION |
125 |
0.0018 |
| 592 |
ORTHOSTATIC HYPOTENSION |
31 |
0.0018 |
| 593 |
BLOOD TEST ABNORMAL |
25 |
0.0018 |
| 594 |
ABDOMINAL DISTENSION |
185 |
0.0018 |
| 595 |
INFLUENZA |
197 |
0.0018 |
| 596 |
SWELLING |
165 |
0.0018 |
| 597 |
PRODUCT USE ISSUE |
331 |
0.0018 |
| 598 |
PERIPHERAL SWELLING |
271 |
0.0018 |
| 599 |
ERUCTATION |
34 |
0.0018 |
| 600 |
STEVENS-JOHNSON SYNDROME |
39 |
0.0018 |
| 601 |
LYMPHADENOPATHY |
62 |
0.0017 |
| 602 |
DEVICE MALFUNCTION |
123 |
0.0017 |
| 603 |
ARTHRALGIA |
727 |
0.0017 |
| 604 |
PRODUCTIVE COUGH |
83 |
0.0017 |
| 605 |
SYNCOPE |
173 |
0.0017 |
| 606 |
EAR INFECTION |
46 |
0.0017 |
| 607 |
INCREASED APPETITE |
33 |
0.0017 |
| 608 |
GASTROINTESTINAL PAIN |
19 |
0.0017 |
| 609 |
DYSARTHRIA |
65 |
0.0017 |
| 610 |
HYPOMAGNESAEMIA |
24 |
0.0017 |
| 611 |
WOUND |
48 |
0.0017 |
| 612 |
JOINT STIFFNESS |
45 |
0.0017 |
| 613 |
PRODUCT DOSE OMISSION ISSUE |
504 |
0.0017 |
| 614 |
RENAL FAILURE ACUTE |
72 |
0.0017 |
| 615 |
DIVERTICULITIS |
47 |
0.0017 |
| 616 |
DIPLOPIA |
44 |
0.0017 |
| 617 |
DRUG LEVEL INCREASED |
28 |
0.0017 |
| 618 |
FLUID RETENTION |
86 |
0.0017 |
| 619 |
THERAPY NON-RESPONDER |
76 |
0.0017 |
| 620 |
MUSCULOSKELETAL PAIN |
88 |
0.0017 |
| 621 |
JOINT SWELLING |
202 |
0.0017 |
| 622 |
EJECTION FRACTION DECREASED |
26 |
0.0017 |
| 623 |
RESTLESSNESS |
61 |
0.0017 |
| 624 |
EYE SWELLING |
62 |
0.0017 |
| 625 |
DRUG INEFFECTIVE |
2193 |
0.0017 |
| 626 |
BONE LOSS |
25 |
0.0017 |
| 627 |
SEPSIS |
185 |
0.0017 |
| 628 |
EXPIRED PRODUCT ADMINISTERED |
55 |
0.0017 |
| 629 |
RENAL DISORDER |
77 |
0.0017 |
| 630 |
PRODUCT PRESCRIBING ISSUE |
36 |
0.0017 |
| 631 |
PULMONARY OEDEMA |
74 |
0.0017 |
| 632 |
ABDOMINAL PAIN |
384 |
0.0016 |
| 633 |
CHEST DISCOMFORT |
169 |
0.0016 |
| 634 |
OESOPHAGITIS |
18 |
0.0016 |
| 635 |
ARRHYTHMIA |
78 |
0.0016 |
| 636 |
HYPERGLYCAEMIA |
60 |
0.0016 |
| 637 |
PANCREATITIS ACUTE |
37 |
0.0016 |
| 638 |
DYSPNOEA EXERTIONAL |
62 |
0.0016 |
| 639 |
INTRAOCULAR PRESSURE INCREASED |
21 |
0.0016 |
| 640 |
ACUTE RESPIRATORY DISTRESS SYNDROME |
29 |
0.0016 |
| 641 |
PAIN IN EXTREMITY |
483 |
0.0016 |
| 642 |
RESPIRATORY TRACT CONGESTION |
26 |
0.0016 |
| 643 |
INJECTION SITE NODULE |
18 |
0.0016 |
| 644 |
ACNE |
124 |
0.0016 |
| 645 |
SKIN REACTION |
23 |
0.0016 |
| 646 |
BLOOD CREATINE PHOSPHOKINASE INCREASED |
47 |
0.0016 |
| 647 |
LUNG DISORDER |
80 |
0.0016 |
| 648 |
THROAT TIGHTNESS |
44 |
0.0016 |
| 649 |
BLOOD PRESSURE FLUCTUATION |
39 |
0.0016 |
| 650 |
SKIN ULCER |
42 |
0.0016 |
| 651 |
GLYCOSYLATED HAEMOGLOBIN INCREASED |
41 |
0.0016 |
| 652 |
RASH PRURITIC |
88 |
0.0016 |
| 653 |
ANAEMIA |
309 |
0.0016 |
| 654 |
SENSORY DISTURBANCE |
26 |
0.0016 |
| 655 |
GAIT DISTURBANCE |
310 |
0.0016 |
| 656 |
ABNORMAL WEIGHT GAIN |
20 |
0.0016 |
| 657 |
RESPIRATORY FAILURE |
118 |
0.0016 |
| 658 |
ACTIVITIES OF DAILY LIVING IMPAIRED |
32 |
0.0016 |
| 659 |
INTENTIONAL DOSE OMISSION |
46 |
0.0016 |
| 660 |
DELUSION |
25 |
0.0016 |
| 661 |
RHINORRHOEA |
104 |
0.0016 |
| 662 |
TOOTH EXTRACTION |
20 |
0.0016 |
| 663 |
DISCOMFORT |
98 |
0.0016 |
| 664 |
HAEMATURIA |
55 |
0.0016 |
| 665 |
THROAT IRRITATION |
72 |
0.0016 |
| 666 |
DEVICE MECHANICAL ISSUE |
22 |
0.0016 |
| 667 |
OEDEMA |
87 |
0.0016 |
| 668 |
ACUTE MYELOID LEUKAEMIA |
25 |
0.0016 |
| 669 |
NERVOUS SYSTEM DISORDER |
50 |
0.0016 |
| 670 |
ARTHRITIS |
126 |
0.0016 |
| 671 |
PARAESTHESIA |
252 |
0.0016 |
| 672 |
HYPOAESTHESIA |
239 |
0.0016 |
| 673 |
MEMORY IMPAIRMENT |
219 |
0.0016 |
| 674 |
MYOCLONUS |
19 |
0.0016 |
| 675 |
BLOOD BILIRUBIN INCREASED |
43 |
0.0016 |
| 676 |
TOOTH LOSS |
33 |
0.0016 |
| 677 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
45 |
0.0016 |
| 678 |
SKIN FISSURES |
31 |
0.0016 |
| 679 |
MULTIPLE FRACTURES |
26 |
0.0016 |
| 680 |
EYE PAIN |
89 |
0.0016 |
| 681 |
TACHYCARDIA |
140 |
0.0016 |
| 682 |
DERMATITIS |
33 |
0.0016 |
| 683 |
NERVOUSNESS |
82 |
0.0016 |
| 684 |
SOMNOLENCE |
316 |
0.0016 |
| 685 |
DYSPEPSIA |
154 |
0.0016 |
| 686 |
ALANINE AMINOTRANSFERASE INCREASED |
96 |
0.0016 |
| 687 |
LOWER LIMB FRACTURE |
30 |
0.0016 |
| 688 |
NIGHTMARE |
54 |
0.0016 |
| 689 |
TREMOR |
259 |
0.0016 |
| 690 |
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION |
111 |
0.0016 |
| 691 |
BLINDNESS UNILATERAL |
22 |
0.0016 |
| 692 |
CARDIAC FAILURE |
125 |
0.0016 |
| 693 |
PALPITATIONS |
182 |
0.0016 |
| 694 |
URINARY INCONTINENCE |
46 |
0.0016 |
| 695 |
HAEMOPTYSIS |
43 |
0.0015 |
| 696 |
FALL |
513 |
0.0015 |
| 697 |
CRYING |
56 |
0.0015 |
| 698 |
MUSCULAR WEAKNESS |
175 |
0.0015 |
| 699 |
BLOOD SODIUM DECREASED |
29 |
0.0015 |
| 700 |
ILEUS |
19 |
0.0015 |
| 701 |
DRY MOUTH |
124 |
0.0015 |
| 702 |
HEPATOTOXICITY |
34 |
0.0015 |
| 703 |
HAIR COLOUR CHANGES |
19 |
0.0015 |
| 704 |
NEOPLASM PROGRESSION |
53 |
0.0015 |
| 705 |
ORAL PAIN |
34 |
0.0015 |
| 706 |
ANKYLOSING SPONDYLITIS |
20 |
0.0015 |
| 707 |
DEHYDRATION |
202 |
0.0015 |
| 708 |
DIZZINESS |
754 |
0.0015 |
| 709 |
GENERALISED TONIC-CLONIC SEIZURE |
25 |
0.0015 |
| 710 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
306 |
0.0015 |
| 711 |
LOSS OF CONSCIOUSNESS |
193 |
0.0015 |
| 712 |
SKIN DISORDER |
50 |
0.0015 |
| 713 |
URINARY RETENTION |
50 |
0.0015 |
| 714 |
PNEUMONIA |
485 |
0.0015 |
| 715 |
DISEASE RECURRENCE |
71 |
0.0015 |
| 716 |
LIMB DISCOMFORT |
46 |
0.0015 |
| 717 |
SKIN CANCER |
32 |
0.0015 |
| 718 |
PELVIC PAIN |
27 |
0.0015 |
| 719 |
HAEMATOCHEZIA |
82 |
0.0015 |
| 720 |
ILLNESS |
153 |
0.0015 |
| 721 |
MUSCLE TIGHTNESS |
24 |
0.0015 |
| 722 |
CEREBRAL HAEMORRHAGE |
53 |
0.0015 |
| 723 |
SINUS CONGESTION |
20 |
0.0015 |
| 724 |
PSORIATIC ARTHROPATHY |
60 |
0.0015 |
| 725 |
PROCEDURAL PAIN |
41 |
0.0015 |
| 726 |
INCORRECT DOSE ADMINISTERED |
337 |
0.0015 |
| 727 |
HEMIPARESIS |
25 |
0.0015 |
| 728 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
77 |
0.0015 |
| 729 |
THERAPY PARTIAL RESPONDER |
23 |
0.0015 |
| 730 |
VIRAL INFECTION |
49 |
0.0015 |
| 731 |
KNEE ARTHROPLASTY |
31 |
0.0015 |
| 732 |
HAEMORRHAGE INTRACRANIAL |
22 |
0.0015 |
| 733 |
RESPIRATORY DISORDER |
44 |
0.0015 |
| 734 |
BODY TEMPERATURE INCREASED |
30 |
0.0015 |
| 735 |
HALLUCINATION, VISUAL |
31 |
0.0015 |
| 736 |
PARALYSIS |
21 |
0.0015 |
| 737 |
CLOSTRIDIUM DIFFICILE INFECTION |
32 |
0.0015 |
| 738 |
ENCEPHALOPATHY |
36 |
0.0015 |
| 739 |
NAUSEA |
1155 |
0.0015 |
| 740 |
SEROTONIN SYNDROME |
28 |
0.0015 |
| 741 |
THIRST |
26 |
0.0015 |
| 742 |
DYSGEUSIA |
108 |
0.0015 |
| 743 |
INFLAMMATION |
75 |
0.0015 |
| 744 |
FEELING HOT |
89 |
0.0015 |
| 745 |
CONDITION AGGRAVATED |
440 |
0.0014 |
| 746 |
FLATULENCE |
82 |
0.0014 |
| 747 |
PROSTATE CANCER |
116 |
0.0014 |
| 748 |
GASTROENTERITIS VIRAL |
26 |
0.0014 |
| 749 |
EPILEPSY |
44 |
0.0014 |
| 750 |
OSTEOMYELITIS |
26 |
0.0014 |
| 751 |
INJECTION SITE SWELLING |
110 |
0.0014 |
| 752 |
PHOTOPHOBIA |
27 |
0.0014 |
| 753 |
AMENORRHOEA |
25 |
0.0014 |
| 754 |
INFLUENZA LIKE ILLNESS |
117 |
0.0014 |
| 755 |
GASTRIC ULCER |
27 |
0.0014 |
| 756 |
DISSEMINATED INTRAVASCULAR COAGULATION |
20 |
0.0014 |
| 757 |
HAIR TEXTURE ABNORMAL |
19 |
0.0014 |
| 758 |
RENAL INJURY |
42 |
0.0014 |
| 759 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
35 |
0.0014 |
| 760 |
ACCIDENTAL EXPOSURE TO PRODUCT |
145 |
0.0014 |
| 761 |
DEVICE BREAKAGE |
57 |
0.0014 |
| 762 |
RASH MACULAR |
49 |
0.0014 |
| 763 |
FEELING COLD |
39 |
0.0014 |
| 764 |
GALLBLADDER DISORDER |
25 |
0.0014 |
| 765 |
SPINAL FRACTURE |
28 |
0.0014 |
| 766 |
BLOOD POTASSIUM DECREASED |
42 |
0.0014 |
| 767 |
TRANSAMINASES INCREASED |
31 |
0.0014 |
| 768 |
BACTERIAL INFECTION |
26 |
0.0014 |
| 769 |
MOBILITY DECREASED |
100 |
0.0014 |
| 770 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
99 |
0.0014 |
| 771 |
COVID-19 |
244 |
0.0014 |
| 772 |
FULL BLOOD COUNT DECREASED |
28 |
0.0014 |
| 773 |
PSYCHOMOTOR HYPERACTIVITY |
23 |
0.0014 |
| 774 |
HALLUCINATION, AUDITORY |
22 |
0.0014 |
| 775 |
FAECES DISCOLOURED |
30 |
0.0014 |
| 776 |
COUGH |
388 |
0.0014 |
| 777 |
SNEEZING |
31 |
0.0014 |
| 778 |
CHILLS |
162 |
0.0014 |
| 779 |
SCIATICA |
22 |
0.0014 |
| 780 |
BLISTER |
77 |
0.0014 |
| 781 |
MUSCULOSKELETAL DISORDER |
26 |
0.0014 |
| 782 |
HYPOKALAEMIA |
63 |
0.0014 |
| 783 |
PLEURAL EFFUSION |
83 |
0.0014 |
| 784 |
HYPOXIA |
48 |
0.0014 |
| 785 |
METABOLIC ACIDOSIS |
43 |
0.0013 |
| 786 |
RESPIRATORY TRACT INFECTION |
35 |
0.0013 |
| 787 |
BREAST CANCER |
125 |
0.0013 |
| 788 |
DYSPNOEA |
759 |
0.0013 |
| 789 |
PERICARDIAL EFFUSION |
31 |
0.0013 |
| 790 |
HERPES ZOSTER |
77 |
0.0013 |
| 791 |
DYSSTASIA |
39 |
0.0013 |
| 792 |
GASTROINTESTINAL HAEMORRHAGE |
111 |
0.0013 |
| 793 |
VISION BLURRED |
182 |
0.0013 |
| 794 |
APHASIA |
40 |
0.0013 |
| 795 |
CONFUSIONAL STATE |
213 |
0.0013 |
| 796 |
RETCHING |
28 |
0.0013 |
| 797 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
236 |
0.0013 |
| 798 |
HYPOKINESIA |
19 |
0.0013 |
| 799 |
DRUG DISPENSING ERROR |
20 |
0.0013 |
| 800 |
UPPER GASTROINTESTINAL HAEMORRHAGE |
22 |
0.0013 |
| 801 |
MALAISE |
573 |
0.0013 |
| 802 |
GASTROENTERITIS |
19 |
0.0013 |
| 803 |
DEAFNESS |
34 |
0.0013 |
| 804 |
DIABETES MELLITUS INADEQUATE CONTROL |
23 |
0.0013 |
| 805 |
HYPOGLYCAEMIA |
63 |
0.0013 |
| 806 |
LYMPHOMA |
20 |
0.0013 |
| 807 |
HEPATIC FAILURE |
39 |
0.0013 |
| 808 |
CATARACT |
77 |
0.0013 |
| 809 |
HUNGER |
18 |
0.0013 |
| 810 |
INFECTION |
187 |
0.0013 |
| 811 |
DECREASED APPETITE |
300 |
0.0013 |
| 812 |
DEVICE DISLOCATION |
56 |
0.0013 |
| 813 |
UNDERDOSE |
94 |
0.0013 |
| 814 |
EAR PAIN |
25 |
0.0013 |
| 815 |
ASPARTATE AMINOTRANSFERASE INCREASED |
68 |
0.0013 |
| 816 |
BLINDNESS |
52 |
0.0013 |
| 817 |
VISUAL IMPAIRMENT |
158 |
0.0013 |
| 818 |
EXPOSURE VIA SKIN CONTACT |
33 |
0.0013 |
| 819 |
PRODUCT DOSE OMISSION IN ERROR |
36 |
0.0013 |
| 820 |
ABDOMINAL DISCOMFORT |
213 |
0.0013 |
| 821 |
MUSCULOSKELETAL STIFFNESS |
111 |
0.0013 |
| 822 |
THERAPY CESSATION |
65 |
0.0013 |
| 823 |
SKIN DISCOLOURATION |
58 |
0.0013 |
| 824 |
TOOTH DISORDER |
28 |
0.0013 |
| 825 |
LIVER FUNCTION TEST INCREASED |
27 |
0.0013 |
| 826 |
ULCER |
20 |
0.0013 |
| 827 |
CYSTITIS |
40 |
0.0013 |
| 828 |
INJECTION SITE PAIN |
385 |
0.0013 |
| 829 |
PERICARDITIS |
21 |
0.0012 |
| 830 |
DEVICE FAILURE |
19 |
0.0012 |
| 831 |
DEVICE LEAKAGE |
54 |
0.0012 |
| 832 |
DYSPHAGIA |
117 |
0.0012 |
| 833 |
SEIZURE |
142 |
0.0012 |
| 834 |
PRODUCT DOSE OMISSION |
80 |
0.0012 |
| 835 |
OCULAR HYPERAEMIA |
58 |
0.0012 |
| 836 |
FREQUENT BOWEL MOVEMENTS |
33 |
0.0012 |
| 837 |
SPEECH DISORDER |
64 |
0.0012 |
| 838 |
VERTIGO |
74 |
0.0012 |
| 839 |
HEPATITIS |
31 |
0.0012 |
| 840 |
DRY EYE |
60 |
0.0012 |
| 841 |
INJECTION SITE HAEMORRHAGE |
96 |
0.0012 |
| 842 |
DIARRHOEA |
774 |
0.0012 |
| 843 |
PNEUMOTHORAX |
19 |
0.0012 |
| 844 |
CHOLESTASIS |
23 |
0.0012 |
| 845 |
HAEMORRHAGE |
125 |
0.0012 |
| 846 |
PHARMACEUTICAL PRODUCT COMPLAINT |
31 |
0.0012 |
| 847 |
OXYGEN SATURATION DECREASED |
67 |
0.0012 |
| 848 |
PYREXIA |
411 |
0.0012 |
| 849 |
FEEDING DISORDER |
24 |
0.0012 |
| 850 |
EYE IRRITATION |
68 |
0.0012 |
| 851 |
WHEEZING |
70 |
0.0012 |
| 852 |
PRURITUS |
453 |
0.0012 |
| 853 |
ABDOMINAL PAIN UPPER |
242 |
0.0012 |
| 854 |
BLOOD PRESSURE DECREASED |
78 |
0.0012 |
| 855 |
HYPOPHAGIA |
30 |
0.0012 |
| 856 |
KIDNEY INFECTION |
23 |
0.0012 |
| 857 |
OSTEONECROSIS OF JAW |
29 |
0.0012 |
| 858 |
BLOOD POTASSIUM INCREASED |
19 |
0.0012 |
| 859 |
MEDICATION ERROR |
65 |
0.0012 |
| 860 |
BLOOD GLUCOSE DECREASED |
56 |
0.0012 |
| 861 |
UNRESPONSIVE TO STIMULI |
30 |
0.0012 |
| 862 |
PNEUMONIA ASPIRATION |
29 |
0.0012 |
| 863 |
GENERAL PHYSICAL HEALTH DETERIORATION |
134 |
0.0012 |
| 864 |
VAGINAL HAEMORRHAGE |
50 |
0.0012 |
| 865 |
ABDOMINAL PAIN LOWER |
29 |
0.0011 |
| 866 |
LOCAL SWELLING |
20 |
0.0011 |
| 867 |
OROPHARYNGEAL PAIN |
106 |
0.0011 |
| 868 |
WHITE BLOOD CELL COUNT DECREASED |
124 |
0.0011 |
| 869 |
DEVICE USE ISSUE |
20 |
0.0011 |
| 870 |
FUNGAL INFECTION |
38 |
0.0011 |
| 871 |
RASH |
490 |
0.0011 |
| 872 |
ASCITES |
33 |
0.0011 |
| 873 |
PRODUCT PREPARATION ERROR |
23 |
0.0011 |
| 874 |
DRUG WITHDRAWAL SYNDROME |
98 |
0.0011 |
| 875 |
RASH PAPULAR |
25 |
0.0011 |
| 876 |
HALLUCINATION |
84 |
0.0011 |
| 877 |
INTESTINAL OBSTRUCTION |
42 |
0.0011 |
| 878 |
SEDATION |
29 |
0.0011 |
| 879 |
DRUG DOSE OMISSION |
183 |
0.0011 |
| 880 |
ALOPECIA |
217 |
0.0011 |
| 881 |
DEVICE ISSUE |
99 |
0.0011 |
| 882 |
VOMITING |
518 |
0.0011 |
| 883 |
HYPOTENSION |
221 |
0.0011 |
| 884 |
PULMONARY FIBROSIS |
21 |
0.0011 |
| 885 |
ERYTHEMA |
224 |
0.0011 |
| 886 |
ANAPHYLACTIC REACTION |
60 |
0.0011 |
| 887 |
RASH GENERALISED |
28 |
0.0011 |
| 888 |
URTICARIA |
181 |
0.0011 |
| 889 |
CONJUNCTIVITIS |
20 |
0.0011 |
| 890 |
CARDIO-RESPIRATORY ARREST |
45 |
0.0011 |
| 891 |
BRADYCARDIA |
57 |
0.0011 |
| 892 |
ASTHMA |
121 |
0.0011 |
| 893 |
ILL-DEFINED DISORDER |
65 |
0.0011 |
| 894 |
INJECTION SITE BRUISING |
85 |
0.0011 |
| 895 |
HAEMATEMESIS |
27 |
0.0011 |
| 896 |
BLOOD GLUCOSE INCREASED |
200 |
0.0011 |
| 897 |
GASTROINTESTINAL DISORDER |
95 |
0.0011 |
| 898 |
INJECTION SITE URTICARIA |
26 |
0.0011 |
| 899 |
ADVERSE DRUG REACTION |
95 |
0.0011 |
| 900 |
RESPIRATORY DISTRESS |
29 |
0.0010 |
| 901 |
DRUG EFFECT INCOMPLETE |
38 |
0.0010 |
| 902 |
URINARY TRACT INFECTION |
178 |
0.0010 |
| 903 |
DRUG PRESCRIBING ERROR |
20 |
0.0010 |
| 904 |
FEMUR FRACTURE |
32 |
0.0010 |
| 905 |
THERAPEUTIC RESPONSE SHORTENED |
34 |
0.0010 |
| 906 |
ORAL HERPES |
20 |
0.0010 |
| 907 |
VISUAL ACUITY REDUCED |
34 |
0.0010 |
| 908 |
NASOPHARYNGITIS |
188 |
0.0010 |
| 909 |
INCORRECT PRODUCT ADMINISTRATION DURATION |
22 |
0.0010 |
| 910 |
NEUTROPENIA |
138 |
0.0010 |
| 911 |
SKIN IRRITATION |
46 |
0.0010 |
| 912 |
RASH ERYTHEMATOUS |
48 |
0.0010 |
| 913 |
LIVER DISORDER |
44 |
0.0010 |
| 914 |
HEPATIC FUNCTION ABNORMAL |
37 |
0.0010 |
| 915 |
CONTRAINDICATED PRODUCT ADMINISTERED |
30 |
0.0010 |
| 916 |
GLAUCOMA |
19 |
0.0010 |
| 917 |
TASTE DISORDER |
20 |
0.0010 |
| 918 |
WRONG TECHNIQUE IN DEVICE USAGE PROCESS |
46 |
0.0010 |
| 919 |
COLITIS ULCERATIVE |
44 |
0.0010 |
| 920 |
EYE PRURITUS |
33 |
0.0010 |
| 921 |
MOVEMENT DISORDER |
31 |
0.0010 |
| 922 |
WRONG TECHNIQUE IN DRUG USAGE PROCESS |
35 |
0.0010 |
| 923 |
HEPATIC CIRRHOSIS |
18 |
0.0010 |
| 924 |
MOUTH ULCERATION |
20 |
0.0009 |
| 925 |
ELECTROCARDIOGRAM QT PROLONGED |
34 |
0.0009 |
| 926 |
GLOSSODYNIA |
21 |
0.0009 |
| 927 |
ECZEMA |
49 |
0.0009 |
| 928 |
DRUG RESISTANCE |
24 |
0.0009 |
| 929 |
PSORIASIS |
122 |
0.0009 |
| 930 |
HIP FRACTURE |
30 |
0.0009 |
| 931 |
ABASIA |
23 |
0.0009 |
| 932 |
SUICIDE ATTEMPT |
56 |
0.0009 |
| 933 |
DERMATITIS ATOPIC |
48 |
0.0009 |
| 934 |
DRY SKIN |
120 |
0.0009 |
| 935 |
PANCYTOPENIA |
50 |
0.0009 |
| 936 |
INTENTIONAL SELF-INJURY |
18 |
0.0009 |
| 937 |
SKIN EXFOLIATION |
75 |
0.0009 |
| 938 |
EYE DISORDER |
29 |
0.0009 |
| 939 |
PNEUMONITIS |
24 |
0.0009 |
| 940 |
GAIT INABILITY |
29 |
0.0009 |
| 941 |
THERAPY INTERRUPTED |
62 |
0.0009 |
| 942 |
RECTAL HAEMORRHAGE |
37 |
0.0009 |
| 943 |
INTENTIONAL DRUG MISUSE |
18 |
0.0009 |
| 944 |
NEUTROPHIL COUNT DECREASED |
35 |
0.0009 |
| 945 |
STOMATITIS |
52 |
0.0009 |
| 946 |
INJECTION SITE PRURITUS |
57 |
0.0009 |
| 947 |
DYSKINESIA |
34 |
0.0008 |
| 948 |
ALTERED STATE OF CONSCIOUSNESS |
18 |
0.0008 |
| 949 |
SEPTIC SHOCK |
36 |
0.0008 |
| 950 |
CONVULSION |
47 |
0.0008 |
| 951 |
COLITIS |
31 |
0.0008 |
| 952 |
GASTRIC DISORDER |
28 |
0.0008 |
| 953 |
INJECTION SITE ERYTHEMA |
100 |
0.0008 |
| 954 |
TREATMENT FAILURE |
66 |
0.0008 |
| 955 |
ADVERSE EVENT |
73 |
0.0008 |
| 956 |
INJECTION SITE REACTION |
54 |
0.0008 |
| 957 |
DELIRIUM |
27 |
0.0008 |
| 958 |
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS |
20 |
0.0008 |
| 959 |
DISEASE PROGRESSION |
90 |
0.0008 |
| 960 |
COMA |
36 |
0.0008 |
| 961 |
DEMENTIA |
21 |
0.0008 |
| 962 |
COMPLETED SUICIDE |
62 |
0.0007 |
| 963 |
HYPOACUSIS |
32 |
0.0007 |
| 964 |
PAIN OF SKIN |
20 |
0.0007 |
| 965 |
EXTRA DOSE ADMINISTERED |
30 |
0.0007 |
| 966 |
ACCIDENTAL OVERDOSE |
27 |
0.0007 |
| 967 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
29 |
0.0007 |
| 968 |
NEOPLASM MALIGNANT |
48 |
0.0007 |
| 969 |
DEATH |
580 |
0.0007 |
| 970 |
HOSPITALISATION |
103 |
0.0007 |
| 971 |
LUNG NEOPLASM MALIGNANT |
27 |
0.0007 |
| 972 |
INJECTION SITE RASH |
20 |
0.0007 |
| 973 |
PLASMA CELL MYELOMA |
25 |
0.0006 |
| 974 |
LIP SWELLING |
21 |
0.0006 |
| 975 |
MULTIPLE SCLEROSIS |
29 |
0.0006 |
| 976 |
DEVICE USE ERROR |
21 |
0.0006 |
| 977 |
OVERDOSE |
130 |
0.0006 |
| 978 |
INTENTIONAL OVERDOSE |
38 |
0.0006 |
| 979 |
SYSTEMIC LUPUS ERYTHEMATOSUS |
20 |
0.0006 |
| 980 |
FEBRILE NEUTROPENIA |
37 |
0.0006 |
| 981 |
LOWER RESPIRATORY TRACT INFECTION |
25 |
0.0005 |
| 982 |
MALIGNANT NEOPLASM PROGRESSION |
55 |
0.0005 |
| 983 |
C-REACTIVE PROTEIN INCREASED |
19 |
0.0005 |
| 984 |
SKIN BURNING SENSATION |
37 |
0.0005 |
| 985 |
RHEUMATOID ARTHRITIS |
58 |
0.0005 |
| 986 |
MULTIPLE SCLEROSIS RELAPSE |
34 |
0.0005 |
| 987 |
TOXICITY TO VARIOUS AGENTS |
81 |
0.0005 |
| 988 |
INTERSTITIAL LUNG DISEASE |
23 |
0.0005 |
| 989 |
LEUKOPENIA |
23 |
0.0005 |
| 990 |
DEVICE EXPULSION |
26 |
0.0004 |
| 991 |
DRUG DEPENDENCE |
55 |
0.0003 |
| 992 |
BLADDER CANCER |
20 |
0.0003 |
| 993 |
DEVICE DIFFICULT TO USE |
21 |
0.0003 |